HIGHLIGHTS
- who: Mia Ravn Jacobsen from the Methods: All consecutive patients with STEMI admitted to Copenhagen University Hospital, Rigshospitalet, fromDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark have published the article: Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction, in the Journal: (JOURNAL)
- what: The authors report superior effectiveness of prasugrel compared with clopi dogrel treatment at 1 year driven by a reduction in all-cause mortality and incidence of ischemic events. The study showed no difference in comparative effectiveness or safety at 1 year between prasugrel and ticagrelor treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.